Q3 2023 · 13F-HR
Deep Track Capital, LPholdings as filed
Filed 2023-11-14 · accession 0001856083-23-000005
$2.59B
Reported value
63
Positions
2023-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 457669307 | INSM | INSMED INC | $151.5M | 5.85% | 6,000,000 | Common | SOLE |
| G50871105 | JAZZ | JAZZ PHARMACEUTICALS PLC | $147.3M | 5.69% | 1,138,045 | Common | SOLE |
| 46116X101 | ITCIEUR | INTRA-CELLULAR THERAPIES INC | $135.4M | 5.23% | 2,600,000 | Common | SOLE |
| 462222100 | IONS | IONIS PHARMACEUTICALS INC | $128.6M | 4.96% | 2,834,069 | Common | SOLE |
| 40131M109 | GH | GUARDANT HEALTH INC | $120.0M | 4.63% | 4,050,000 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $107.4M | 4.15% | 2,797,955 | Common | SOLE |
| G01767105 | ALKS | ALKERMES PLC | $106.4M | 4.11% | 3,800,000 | Common | SOLE |
| 268158201 | DVAX | DYNAVAX TECHNOLOGIES CORP | $99.8M | 3.85% | 6,756,956 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $96.6M | 3.73% | 1,915,000 | Common | SOLE |
| 729139105 | PLRX | PLIANT THERAPEUTICS INC | $95.4M | 3.68% | 5,500,000 | Common | SOLE |
| 85205L107 | SWTXUSD | SPRINGWORKS THERAPEUTICS INC | $82.0M | 3.16% | 3,546,435 | Common | SOLE |
| 05464T104 | AXSM | AXSOME THERAPEUTICS INC | $79.7M | 3.08% | 1,140,745 | Common | SOLE |
| 088786108 | BCYC | BICYCLE THERAPEUTICS PLC | $70.1M | 2.71% | 3,490,506 | Common | SOLE |
| 89422G107 | TVTX | TRAVERE THERAPEUTICS INC | $65.9M | 2.54% | 7,370,000 | Common | SOLE |
| 45826J105 | NTLA | INTELLIA THERAPEUTICS INC | $63.2M | 2.44% | 2,000,000 | Common | SOLE |
| 28106W103 | EDIT | EDITAS MEDICINE INC | $55.4M | 2.14% | 7,101,935 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $54.5M | 2.10% | 25,700,000 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $52.0M | 2.01% | 3,187,415 | Common | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $51.4M | 1.98% | 2,414,373 | Common | SOLE |
| 69404D108 | PACB | PACIFIC BIOSCIENCES CALIF IN | $50.1M | 1.93% | 6,000,000 | Common | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $45.5M | 1.75% | 2,963,267 | Common | SOLE |
| G6674U108 | NVCR | NOVOCURE LTD | $40.4M | 1.56% | 2,500,000 | Common | SOLE |
| 43157M102 | — | HILLEVAX INC | $39.0M | 1.51% | 2,900,000 | Common | SOLE |
| 760273102 | RPTX | REPARE THERAPEUTICS INC | $37.1M | 1.43% | 3,067,731 | Common | SOLE |
| 00847G705 | AGENEUR | AGENUS INC | $35.8M | 1.38% | 31,697,539 | Common | SOLE |
| 35104E100 | FDMT | 4D MOLECULAR THERAPEUTICS IN | $35.4M | 1.37% | 2,778,107 | Common | SOLE |
| 05280R100 | AUTL | AUTOLUS THERAPEUTICS PLC | $35.0M | 1.35% | 15,000,000 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $33.8M | 1.30% | 300,000 | Common | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $30.2M | 1.16% | 6,000,000 | Common | SOLE |
| 75382E109 | — | RAPT THERAPEUTICS INC | $24.9M | 0.96% | 1,500,000 | Common | SOLE |
| 07373V105 | BEAM | BEAM THERAPEUTICS INC | $24.4M | 0.94% | 1,015,641 | Common | SOLE |
| 032724106 | ANAB | ANAPTYSBIO INC | $24.2M | 0.93% | 1,345,813 | Common | SOLE |
| 68062P106 | OLMA | OLEMA PHARMACEUTICALS INC | $23.8M | 0.92% | 1,930,894 | Common | SOLE |
| 67080M103 | NRIX | NURIX THERAPEUTICS INC | $23.6M | 0.91% | 2,997,830 | Common | SOLE |
| 00182C103 | ANIP | ANI PHARMACEUTICALS INC | $23.2M | 0.90% | 400,000 | Common | SOLE |
| 03237H101 | AMLX | AMYLYX PHARMACEUTICALS INC | $23.1M | 0.89% | 1,259,335 | Common | SOLE |
| 09075V102 | BNTX | BIONTECH SE | $21.7M | 0.84% | 200,000 | Common | SOLE |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $21.5M | 0.83% | 2,403,672 | Common | SOLE |
| 60770K107 | MRNA | MODERNA INC | $20.7M | 0.80% | 200,000 | Common | SOLE |
| 82686Q101 | SLN | SILENCE THERAPEUTICS PLC | $19.2M | 0.74% | 1,951,580 | Common | SOLE |
| 730541109 | — | POINT BIOPHARMA GLOBAL INC | $18.6M | 0.72% | 2,781,565 | Common | SOLE |
| G9TY5A101 | ZURA | ZURA BIO LTD | $16.7M | 0.64% | 2,523,000 | Common | SOLE |
| 68570P200 | — | ORCHARD THERAPEUTICS PLC | $15.8M | 0.61% | 2,041,670 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $15.8M | 0.61% | 2,750,000 | Common | SOLE |
| G72800108 | PRTA | PROTHENA CORP PLC | $12.1M | 0.47% | 250,000 | PUT | SOLE |
| 640268108 | NKTREUR | NEKTAR THERAPEUTICS | $11.0M | 0.42% | 18,400,000 | Common | SOLE |
| 61775R105 | MORFUSD | MORPHIC HLDG INC | $10.8M | 0.42% | 470,647 | Common | SOLE |
| 00847X104 | AGIO | AGIOS PHARMACEUTICALS INC | $10.5M | 0.40% | 422,247 | Common | SOLE |
| 00509G209 | ABOS | ACUMEN PHARMACEUTICALS INC | $10.4M | 0.40% | 2,513,044 | Common | SOLE |
| 67080N101 | NUVB | NUVATION BIO INC | $10.3M | 0.40% | 7,720,688 | Common | SOLE |
| 92673K108 | VIGL | VIGIL NEUROSCIENCE INC | $9.5M | 0.37% | 1,767,131 | Common | SOLE |
| 75955J402 | RLMD | RELMADA THERAPEUTICS INC | $8.5M | 0.33% | 2,837,818 | Common | SOLE |
| 04635X102 | CATBUSD | ASTRIA THERAPEUTICS INC | $7.7M | 0.30% | 1,037,873 | Common | SOLE |
| 88025U109 | TXG | 10X GENOMICS INC | $7.5M | 0.29% | 182,691 | Common | SOLE |
| 670002401 | NVAX | NOVAVAX INC | $7.2M | 0.28% | 1,000,000 | Common | SOLE |
| 00445A100 | — | ACELYRIN INC | $5.6M | 0.22% | 551,289 | Common | SOLE |
| G3855L106 | GHRS | GH RESEARCH PLC | $5.0M | 0.19% | 499,400 | Common | SOLE |
| 87184Q206 | SYRS | SYROS PHARMACEUTICALS INC | $3.3M | 0.13% | 828,485 | Common | SOLE |
| 80706P103 | SRRK | SCHOLAR ROCK HLDG CORP | $2.5M | 0.10% | 353,855 | Common | SOLE |
| 20451W101 | CMPS | COMPASS PATHWAYS PLC | $2.4M | 0.09% | 328,424 | Common | SOLE |
| 427746102 | HRTX | HERON THERAPEUTICS INC | $2.1M | 0.08% | 2,086,704 | Common | SOLE |
| 282559103 | ETNBGBP | 89BIO INC | $1.4M | 0.05% | 91,078 | Common | SOLE |
| 15673T100 | IPSC | CENTURY THERAPEUTICS INC | $1.1M | 0.04% | 543,008 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.